BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bifidobacterium longum {B.Longum } - Citrobacter |
👶
Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. Journal of applied microbiology (J Appl Microbiol ) Vol: 100 Issue 6 Pages: 1324-32 Pub: 2006 Jun Epub: Authors Hütt P , Shchepetova J , Lõivukene K , Kullisaar T , Mikelsaar M , Publication Publication |
| bifidobacterium longum {B.Longum } - Citrobacter |
👶
Bifidobacterium longum subsp. longum 51A attenuates intestinal injury against irinotecan-induced mucositis in mice. Life sciences (Life Sci ) Vol: 289 Issue Pages: 120243 Pub: 2022 Jan 15 Epub: 2021 Dec 16 Authors Quintanilha MF , Miranda VC , Souza RO , Gallotti B , Cruz C , Santos EA , Alvarez-Leite JI , Jesus LCL , Azevedo V , Trindade LM , Cardoso VN , Ferreira E , Carvalho BA , Soares PMG , Vieira AT , Nicoli JR , Martins FS , Publication |
| bifidobacterium longum {B.Longum } - Citrobacter |
👶
A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. Food & function (Food Funct ) Vol: 10 Issue 3 Pages: 1595-1608 Pub: 2019 Mar 20 Epub: Authors Yan S , Yang B , Zhao J , Zhao J , Stanton C , Ross RP , Zhang H , Chen W , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
